Retinal Diseases D012164

Diseases [C] » Eye Diseases [C11] » Retinal Diseases

Description

Diseases involving the RETINA.   MeSH

Subtype Terms (22)

Angioid Streaks
4 approved drugs

Central Serous Chorioretinopathy
30 drugs (24 approved, 6 experimental)

Cone Dystrophy
 

Diabetic Retinopathy
153 drugs (72 approved, 81 experimental)

Epiretinal Membrane
23 drugs (18 approved, 5 experimental)

Familial Exudative Vitreoretinopathies
1 approved drug

Hypertensive Retinopathy
 

Leber Congenital Amaurosis
14 drugs (6 approved, 8 experimental)

Retinal Artery Occlusion
8 drugs (6 approved, 2 experimental)

Retinal Degeneration
27 drugs (8 approved, 19 experimental)

Retinal Detachment
37 drugs (30 approved, 7 experimental)

Retinal Dysplasia
 

Retinal Hemorrhage
3 approved drugs

Retinal Neoplasms
8 approved drugs

Retinal Neovascularization
6 drugs (3 approved, 3 experimental)

Retinal Perforations
18 drugs (11 approved, 7 experimental)

Retinal Telangiectasis
6 drugs (4 approved, 2 experimental)

Retinal Vasculitis
4 approved drugs

Retinal Vein Occlusion
44 drugs (29 approved, 15 experimental)

Retinitis
5 drugs (2 approved, 3 experimental)

Retinopathy of Prematurity
44 drugs (28 approved, 16 experimental)

Vitreoretinopathy, Proliferative
27 drugs (23 approved, 4 experimental)


Approved Indicated Drugs (1)


Organization Involved with Phase 3 Indications (90)

Organization Involved with Phase 2 Indications (75)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.